Dr Damien Kee is a medical oncologist and clinician-scientist with expertise in melanoma, rare cancers and precision oncology. He leads the Melanoma and Skin Cancer Tumour Stream at Austin Health and the uveal melanoma clinical trials portfolio at Peter MacCallum Cancer Centre. Dr Kee is Chair of the Clinical Oncology Society of Australia (COSA) Melanoma and Skin Cancer Group, Deputy Chair of the Omico Molecular Oncology Board, and a Governance Committee member of Melanoma Research Victoria. Damien is also the Clinical Lead of the Australian Rare Cancer Portal and a Senior Clinical Research Fellow in the Rare Cancer Laboratory at the Walter and Eliza Hall Institute, where his research focuses on cancer genomics, immunotherapy and improving outcomes for patients with rare cancers.